Bausch + Lomb Corporation reported $5.32B of revenue over the trailing twelve months, +8.9% on the year before. 9 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $5.32B (to Q2 2026). Net income: −$171M, trailing twelve months to Q2 2026. Free cash flow: $137M, trailing twelve months to Q2 2026. Operating margin: 6.0%, trailing twelve months to Q2 2026.

BLCOBausch + Lomb Corporation

Healthcare

$17.32+14% 1Y

$17.32

$14.3252 weeks$18.60

BLCO as reported

Bausch + Lomb Corporation reported $5.32B of revenue over the trailing twelve months, +8.9% on the year before. 9 reported series are charted on this page, each one as filed.

$5.32B

Revenue, trailing twelve months · to Q2 2026 · +8.9% against the twelve months before

Net income: −$171M
Net income · −37% year on year · trailing twelve months to Q2 2026
Free cash flow: $137M
Free cash flow · −183% year on year · trailing twelve months to Q2 2026
Operating margin: 6.0%
Operating margin · trailing twelve months to Q2 2026

Details›

Every series Ryufin has for BLCO, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$5.32B	+8.9%	Q2 2026
Net income	−$171M	−37%	Q2 2026
EPS	−$0.49	−37%	Q2 2026
Operating margin	6.0%	n/a	Q2 2026
Net margin	−3.3%	n/a	Q2 2026
ROE	−4.1%	n/a	Q2 2026
ROA	−1.9%	n/a	Q2 2026
ROIC	1.3%	n/a	Q2 2026
Free cash flow	$137M	−183%	Q2 2026

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.